Figure 1.
Percent of patients with clinical response to eluxadoline in a pooled phase III trial. Adapted from Supplementary Table 1 of Lembo and colleagues.17
Percent of patients with clinical response to eluxadoline in a pooled phase III trial. Adapted from Supplementary Table 1 of Lembo and colleagues.17